Inhibitors of ADAM10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect.
Pece R, Tavella S, Costa D, Varesano S, Camodeca C, Cuffaro D, Nuti E, Rossello A, Alfano M, D'Arrigo C, Galante D, Ravetti JL, Gobbi M, Tosetti F, Poggi A, Zocchi MR.
Pece R, et al. Among authors: galante d, d arrigo c.
Haematologica. 2022 Apr 1;107(4):909-920. doi: 10.3324/haematol.2021.278469.
Haematologica. 2022.
PMID: 34109776
Free PMC article.